Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Skybiotech HealthcareBOM:512036 -0.30%23 Days Inventory is 54.52 as of Mar. 2026, which is 60% below its 10-year median of 136.25. GuruFocus rates BOM:512036 with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 488 Conglomerates companies, Skybiotech Healthcare ranks worse than 68.65% on this metric.
The historical rank and industry rank for Skybiotech Healthcare's Days Inventory or its related term are showing as below:
BOM:512036'
s Days Inventory Range Over the Past 10 Years
Min: 111.77 Med: 136.25 Max: 160.72
Current: 111.98
During the past 13 years, Skybiotech Healthcare's highest Days Inventory was 160.72. The lowest was 111.77. And the median was 136.25.
BOM:512036's Days Inventory is ranked worse than 68.65% of 488
companies
in the Conglomerates industry
Industry Median: 74.11
vs BOM:512036: 111.98
Skybiotech Healthcare's Days Inventory
declined
from Mar. 2025 (181.55) to Mar. 2026 (54.52).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Skybiotech Healthcare's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.67.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Skybiotech Healthcare's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.44.
Skybiotech Healthcare (BOM:512036) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Skybiotech Healthcare's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Skybiotech Healthcare's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Skybiotech Healthcare Days Inventory Related Terms
Skybiotech Healthcare Days Inventory Historical Data
* Premium members only.
The historical data trend for Skybiotech Healthcare's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Skybiotech Healthcare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Skybiotech Healthcare Days Inventory vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Skybiotech Healthcare's Days Inventory distribution charts can be found below:
* The bar in red indicates where Skybiotech Healthcare's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Skybiotech Healthcare (BOM:512036) has a Days Inventory of 54.52 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Skybiotech Healthcare and its competitors. This is 60% below median its historical median of 136.25. Over the past decade, Skybiotech Healthcare's Days Inventory has ranged from 111.77 to 160.72. According to the industry distribution chart, Skybiotech Healthcare ranks #335 out of 488 companies in the Conglomerates industry, placing it in the top 68.6%.
Is Skybiotech Healthcare's Days Inventory too high?
Skybiotech Healthcare's current Days Inventory of 54.52 is 60% below median its 10-year median of 136.25. Over the past 10 years, this metric has ranged from a low of 111.77 to a high of 160.72. The Conglomerates industry median Days Inventory is 74.11. Skybiotech Healthcare's value of 54.52 is 26.4% below this industry median. Based on the distribution chart, Skybiotech Healthcare ranks #335 out of 488 companies in the Conglomerates industry, which is below the industry midpoint. Overall, Skybiotech Healthcare has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Skybiotech Healthcare's Days Inventory compare to MMM and HON?
According to the Conglomerates industry distribution chart, Skybiotech Healthcare ranks #335 out of 488 companies for Days Inventory. This places Skybiotech Healthcare in the lower half of its industry. The industry median Days Inventory is 74.11. Skybiotech Healthcare's value of 54.52 is 26.4% below this benchmark. Historically, Skybiotech Healthcare's own Days Inventory has ranged from 111.77 to 160.72 over the past decade. While the company's 10-year median is 136.25 vs. the industry median of 74.11, Skybiotech Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Conglomerates company?
The median Days Inventory among Conglomerates companies is 74.11, based on 488 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Skybiotech Healthcare's current Days Inventory of 54.52 is 26.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Skybiotech Healthcare and its competitors. For the Conglomerates industry, the median Days Inventory is 74.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Skybiotech Healthcare's current Days Inventory is 54.52, which is 60% below median its own 10-year median of 136.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skybiotech Healthcare stock overvalued right now?
Skybiotech Healthcare (BOM:512036) has a current Days Inventory of 54.52. The current Days Inventory is 54.52, which is 60% below median its 10-year median of 136.25 and 26.4% below the Conglomerates industry median of 74.11. Skybiotech Healthcare's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Skybiotech Healthcare (BOM:512036), the current Days Inventory is 54.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Skybiotech Healthcare Ltd, formerly Kapil Cotex Ltd is engaged in textiles and allied products, including dyeing, printing, spinning, weaving, and manufacturing fabrics from raw cotton. During the year under review, the company has not generated any revenue from its core business activities. Instead, it earned income from consultancy services for foreign clients and from investments in shares, generating capital gains and dividends. The company's current revenue mainly comes from these non-core activities rather than textile manufacturing.
23GF Score
Get the complete analysis for BOM:512036
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:512036 has been successfully added to your 
